CoChat

Gain‐of‐function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K‐ras

Open access
Acin, Sergio, Li, Zhongyou, Mejia, Olga, Roop, Dennis R, El‐Naggar, Adel K, Caulin, Carlos · 2011 · The Journal of Pathology
Cited by 49

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Mutations in p53 occur in over 50% of the human head and neck squamous cell carcinomas (SCCHN). The majority of these mutations result in the expression of mutant forms of p53, rather than deletions in the p53 gene. Some p53 mutants are associated with poor prognosis in SCCHN patients. However, the molecular mechanisms that determine the poor outcome of cancers carrying p53 mutations are unknown. Here, we generated a mouse model for SCCHN and found that activation of the endogenous p53 gain‐of‐function mutation p53 $^{\rm{R172H}}$ , but not deletion of p53 , cooperates with oncogenic K‐ras during SCCHN initiation, accelerates oral tumour growth, and promotes progression to carcinoma. Mechanistically, expression profiling of the tumours that developed in these mice and studies using cell lines derived from these tumours determined that mutant p53 induces the expression of genes involved in mitosis, including cyclin B1 and cyclin A, and accelerates entry in mitosis. Additionally, we discovered that this oncogenic function of mutant p53 was dependent on K‐ras because the expression of cyclin B1 and cyclin A decreased, and entry in mitosis was delayed, after suppressing K‐ras expression in oral tumour cells that express p53 $^{\rm{R172H}}$ . The presence of double‐strand breaks in the tumours suggests that oncogene‐dependent DNA damage resulting from K‐ras activation promotes the oncogenic function of mutant p53. Accordingly, DNA damage induced by doxorubicin also induced increased expression of cyclin B1 and cyclin A in cells that express p53 $^{\rm{R172H}}$ . These findings represent strong in vivo evidence for an oncogenic function of endogenous p53 gain‐of‐function mutations in SCCHN and provide a mechanistic explanation for the genetic interaction between oncogenic K‐ras and mutant p53. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/path.2971

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 49

Metadata

Authors
Acin, S., Li, Z., Mejia, O., Roop, D. R., El‐Naggar, A. K., & Caulin, C.
Venue
The Journal of Pathology
Publisher
Wiley
Published
2011-09-26
Volume
225
Issue
4
Pages
479-489
ISSN
  • 0022-3417 (ISSN-L)
  • 1096-9896
OpenAlex
W1987584071
Cited by
49
References
12
FWCI
3.03
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gain‐of‐function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K‐ras. https://app.cochat.ai/papers/10.1002/path.2971
The paper
Acin, S., Li, Z., Mejia, O., Roop, D. R., El‐Naggar, A. K., & Caulin, C. (2011). Gain‐of‐function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K‐ras. The Journal of Pathology. https://doi.org/10.1002/path.2971

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.